280 related articles for article (PubMed ID: 12661577)
1. Treatment of latent tuberculosis infection.
Lepage P
N Engl J Med; 2003 Mar; 348(13):1292-3; author reply 1292-3. PubMed ID: 12661577
[No Abstract] [Full Text] [Related]
2. New approaches to the treatment of latent tuberculosis.
Sterling TR
Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
[TBL] [Abstract][Full Text] [Related]
3. Modern treatment of tuberculosis.
Dutt AK; Stead WW
Compr Ther; 1982 Sep; 8(9):19-28. PubMed ID: 7140206
[No Abstract] [Full Text] [Related]
4. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens.
Lambert LA; Ijaz K; Navin TR
Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748
[No Abstract] [Full Text] [Related]
5. [Our experience in short-course treatment of tuberculosis. Results obtained by using therapeutic regimens of 6 to 8 months].
Ben Kheder A; Chabbou A; Zakhama B; Zaimi M; el Gharbi T; el Mekki L; el Gharbi B
Bull Int Union Tuberc; 1985; 60(1-2):26-8. PubMed ID: 4074968
[No Abstract] [Full Text] [Related]
6. [Treatment of tuberculosis].
Broquié G
Soins; 1982 May; 27(9):31-4. PubMed ID: 6920111
[No Abstract] [Full Text] [Related]
7. Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens.
Lincoln T; Brannan GL; Lynch V; Conklin TJ; Clancey T; Rose DN; Tuthill RJ
Int J Tuberc Lung Dis; 2004 Mar; 8(3):306-11. PubMed ID: 15139468
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis treatment: dangerous regimens?
Rieder HL; Arnadottir T; Trébucq A; Enarson DA
Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
[No Abstract] [Full Text] [Related]
9. [Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination (author's transl)].
Kondo E; Kanai K
Kekkaku; 1977 Aug; 52(8):373-6. PubMed ID: 916488
[No Abstract] [Full Text] [Related]
10. Treatment of latent tuberculosis infection.
Parekh MJ; Schluger NW
Ther Adv Respir Dis; 2013 Dec; 7(6):351-6. PubMed ID: 24056289
[TBL] [Abstract][Full Text] [Related]
11. Twelve doses for tuberculosis prevention--review of a new evidenced based regimen.
Byers P
J Miss State Med Assoc; 2012 Aug; 53(8):266. PubMed ID: 23094387
[No Abstract] [Full Text] [Related]
12. Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months.
Menzies D; Dion MJ; Rabinovitch B; Mannix S; Brassard P; Schwartzman K
Am J Respir Crit Care Med; 2004 Aug; 170(4):445-9. PubMed ID: 15172892
[TBL] [Abstract][Full Text] [Related]
13. In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection.
Menzies D; Dion MJ; Francis D; Parisien I; Rocher I; Mannix S; Schwartzman K
Int J Tuberc Lung Dis; 2005 Dec; 9(12):1343-8. PubMed ID: 16466056
[TBL] [Abstract][Full Text] [Related]
14. [Complex hospital treatment of pulmonary tuberculosis].
Bondarev IM; Batmanov NIa; Shesterina MV; Gavrilenko VS; Tarasova EF
Sov Med; 1980; (6):79-82. PubMed ID: 6998023
[No Abstract] [Full Text] [Related]
15. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
[TBL] [Abstract][Full Text] [Related]
16. [Short-term intensive therapy of destructive pulmonary tuberculosis].
Bondarev IM; Zhigalina LI; Kunichan AD
Probl Tuberk; 1980 Dec; (12):57-9. PubMed ID: 7220536
[No Abstract] [Full Text] [Related]
17. Tolerability of rifampin monotherapy for latent tuberculosis infection in children.
Daskalaki I; Byun J; Dogbey MC; Tolbert-Warren C; Watson BM
Pediatr Infect Dis J; 2011 Nov; 30(11):1014-5. PubMed ID: 21997666
[No Abstract] [Full Text] [Related]
18. Latent Mycobacterium tuberculosis infection.
Getahun H; Matteelli A; Chaisson RE; Raviglione M
N Engl J Med; 2015 May; 372(22):2127-35. PubMed ID: 26017823
[No Abstract] [Full Text] [Related]
19. [Current state of the short-course chemotherapy. Apropos of the International Round Table in Florence].
Larbaoui D
Bull Int Union Tuberc; 1985; 60(1-2):18-25. PubMed ID: 4074967
[No Abstract] [Full Text] [Related]
20. [Experimental study of therapeutic effect of various antibacterial drug combinations].
Kozulitsyna TI; Uvarova OA; Golyshevskaia VI; El'shanskaia MP
Probl Tuberk; 1980 Jul; (7):49-53. PubMed ID: 7413637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
